1. A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study
   Umut Riza Gündüz et al, 2016 CrossRef
2. Assessing N w-hydroxy-l-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker
   Srinidi Mohan et al, 2017, Amino Acids CrossRef
3. Improving biosensing activity to carcinoembryonic antigen with orientated single domain antibodies
   Jinny L. Liu et al, 2017, Heliyon CrossRef
4. Thioredoxin-1 and MMP-9 as biomarkers in breast cancer metastasis in Egyptian female patients
   Al Shaima G. Abd El Salam et al, 2018, Egyptian Journal of Basic and Applied Sciences CrossRef
5. The challenge of evaluating adnexal masses in breast cancer patients
   Tomás Reinert et al, 2018, Clinical Breast Cancer CrossRef
6. The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
   Mingjian Lian et al, 2019, J Clin Lab Anal CrossRef
7. Translational progress on tumor biomarkers
   Hongwei Guo et al, 2015, Thoracic Cancer CrossRef
8. Immunotherapeutic options on the horizon in breast cancer treatment
   Johan M. van Rooijen et al, 2015, Pharmacology & Therapeutics CrossRef
9. Intérêt clinique du CA 15-3 dans la détection précoce des récidives de cancer du sein localement avancé
   Stéphane Konan et al, 2015, Bulletin du Cancer CrossRef
10. ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3
    Jean-Marc Riedinger et al, 2016, Bulletin du Cancer CrossRef
11. Tumor markers of breast cancer: New prospectives
    Ahmed M. Kabel, 2017, Journal of Oncological Sciences CrossRef
12. Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods
    Lu Li et al, 2017, CBM CrossRef
13. Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT
    Esra Arslan et al, 2020, Rev. Assoc. Med. Bras. CrossRef
14. An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry
    Turkan Yigitbasi et al, 2018, biom rep CrossRef
15. Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases
    Iman Mamdouh Talaat et al, 2020, Sci Rep CrossRef
16. null
    Zahraa Mohammed AL-Nafakh et al, 2020 CrossRef
17. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
    Mariela Montaño-Samaniego et al, 2020, Front. Oncol. CrossRef
18. Type IV collagen as a potential biomarker of metastatic breast cancer
    Moa Lindgren et al, 2021, Clin Exp Metastasis CrossRef
19. The Utility of Serum Tumor Markers CEA and CA 15-3 for Breast Cancer Prognosis and Their Association With Clinicopathological Parameters
    Meliha Melin Uygur et al, 2021, Cancer Treatment and Research Communications CrossRef
20. Association between molecular subtype of local advanced breast cancer with Ca 15-3 level
    Dony Ruswendro et al, 2021, BD CrossRef
21. Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
    L. De Cock et al, 2021, ESMO Open CrossRef
22. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer
    Jingya Zhang et al, 2021, Clinica Chimica Acta CrossRef
23. Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer
    Gamal A. Elfar et al, 2017, oncol res CrossRef
24. Comparison of Serum Human Epididymis Protein 4 (HE4) Levels in Breast Cancer Patients and Healthy Individuals
    Zahra Honarvar et al, 2021, Indian J Gynecol Oncolog CrossRef
25. Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer
    Luca Urso et al, 2022 CrossRef
26. Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
    Julien Chedid et al, 2022, SAGE Open Medicine CrossRef
27. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
    Thattungal Manoharan Anoop et al, 2022, WJCO CrossRef
28. Diagnostic and Prognostic Role of Serum Omentin and NGAL Levels in Egyptian Breast Cancer Patients
    Al-Shimaa Mahmoud Abas et al, 2022, International Journal of Breast Cancer CrossRef
29. Monitoring of postoperative neutrophil-to-lymphocyte ratio, D-dimer, and CA153 in: Diagnostic value for recurrent and metastatic breast cancer
    Zhiyao Ren et al, 2023, Front. Surg. CrossRef
30. A Review of Salivary Biomarkers in Breast Cancer
    Maryam Koopaie et al, 2023, CWHR CrossRef
31. Analysis of Common Mutation of P53 Gene in Male with Lung Cancer in Mosul City
    Owayes M. Hamed, 2022, RB CrossRef
32. Potential Antitumor Effect of α-Mangostin against Rat Mammary Gland Tumors Induced by LA7 Cells
    Mohamed Yousif Ibrahim et al, 2023, IJMS CrossRef
33. Evre III-B meme kanserli hastalarda CEA ve CA 15-3 düzeylerinin takipteki önemi
    Doğan ÖZTÜRK et al, 2023, TJCL CrossRef
34. The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters
    Vlad Bogdan Varzaru et al, 2024, Life CrossRef